The Dr Louise Newson Podcast

Dr Louise Newson

Have a menopause question? You’ll find the answers here. Join me, GP and Menopause Specialist Dr Louise Newson, for the definitive perimenopause and menopause podcast. Each week I’m joined by a special guest for the lowdown on the latest research and treatments, bust myths and share inspirational stories. This podcast is brought to you by the Newson Health Group, which has clinics across the UK dedicated to providing personalised perimenopause and menopause care for all women. It funds cutting-edge menopause research and creates clinical-led education programmes for healthcare professionals. It also funds the award-winning balance menopause support app, which provides free menopause resources and support to millions of people worldwide, empowering and enabling women to have choice and control over their perimenopause and menopause treatment. read less
Health & FitnessHealth & Fitness

Episodes

249 - Dr Mary Claire Haver: on a mission to demystify menopause
Mar 26 2024
249 - Dr Mary Claire Haver: on a mission to demystify menopause
In this week’s podcast Dr Louise is joined by Dr Mary Claire Haver, an obstetrics and gynaecology doctor and a menopause specialist in the US. Dr Louise and Dr Mary Claire discuss the challenges of ensuring all women have access to evidence-based information and treatment, and their hopes for change. Dr Mary Claire shares her three tips to help menopausal women improve their health: Really focus on your nutrition. Make sure you're getting adequate fibre in your diet every day. Fibre-rich goods are good for you gut microbiome, help you stay full for longer, and are good sources of vitamins, minerals and nutrients.Limit added sugars – those that are added in cooking and processing - to less than 25g per day. Women who do that consistently have less visceral fat. Visceral fat is tied to increased risk of chronic inflammatory diseases.Don't just focus on cardio for your movement. You really need to keep your muscles strong so at least two days a week pick up some weights. Multiple studies in menopausal women show much better outcomes for osteoporosis with resistance training.You can follow Dr Mary Claire on Instagram at @drmaryclaire Click here to find out more about Newson Health Pre-order the revised and updated paperback edition of Dr Louise’s Sunday Times bestseller The Definitive Guide to the Perimenopause and Menopause here   References to studies discussed in this week's episode J Gen Intern Med 2006; 21:363–6 J Gen Intern Med 2004;19:791–804 Am J Med 2009;122:1016 – 22 JAMA 2004; 291:2243 – 52 Int J Cardiol 2010;138:25 – 31 Urology 2024; Jan 29:S0090-4295(24)00006-2
244 - Hot flush drug fezolinetant
Feb 20 2024
244 - Hot flush drug fezolinetant
On this week’s podcast, Dr Louise is joined by Dr Ashley Winter, a urologist and sexual medicine specialist, and Dr Sarah Glynne, a GP and menopause specialist who is a member of the research team at Newson Health and chairs a working party that promotes access to evidence-based menopause care for patients with breast cancer. They discuss Fezolinetant – brand name Veoza – a new drug recently approved in the UK and other countries to treat moderate to severe hot flushes in menopausal women aged 45 to 60 years. You can read an article about fezolinetant on the balance website here. Related articles Lederman S., Ottery F.D., Cano A., Santoro N., Shapiro M., Stute P., et al. (2023) 'Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study', Lancet, 401(10382):1091-102. doi.org/10.1016/S0140-6736(23)00085-5 Johnson K.A., Martin N., Nappi R.E., Neal-Perry G., Shapiro M., Stute P., et al. (2023), 'Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: a Phase 3 RCT', J Clin Endocrinol Metab, 108(8):1981-97. Doi:10.1210/clinem/dgad058 Douxfils J., Beaudart C., Dogne J.M. (2023), 'Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant', Lancet, 402(10413):1623-5. doi.org/10.1016/S0140-6736(23)01634-3 Follow Dr Ashley Winter on X and Instagram @ashleygwinter Follow Dr Sarah Glynne on Instagram @sarahglynne Click here to find out more about Newson Health
235 - Menopause and brain health: what’s the link?
Dec 19 2023
235 - Menopause and brain health: what’s the link?
In this episode Dr Louise is joined by world-renowned neuroscientist Dr Lisa Mosconi, PhD. Dr Lisa is Director of the Alzheimer’s Prevention Clinic and Women’s Brain Initiative at Weill Cornell Medicine in New York and author of bestsellers The XX Brain and Brain Food. Dr Lisa was studying nuclear medicine and neuroscience when her grandmother and her grandmother’s three sisters all developed Alzheimer's. Dr Lisa became interested in the cause of Alzheimer’s and why women are more susceptible. Her research has shown that, rather than a disease of old age, it starts in midlife and menopause potentially plays a part. Dr Lisa discusses her most recent paper, which found that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken oestrogen. Finally, Dr Lisa shares three things to consider about female hormones: Oestrogen, and oestradiol in particular, is the master regulator of women's brains. It really is like saying that oestrogen is to your brain what fuel is for an engine. It keeps your brain running.Endogenous oestrogen (produced within your body) is different from exogenous oestrogen (synthetic). The bioidentical oestradiol is probably the best one to use because it really maps on the same circuits for your own endogenous oestrogen.I would love for all women to be able to make an informed decision about whether or not hormone therapy is a viable option for them. Many women who are eligible for HRT do not go on HRT out of fear and the fear comes from outdated information, mislabelling on some of the packages. Follow Dr Lisa on Instagram @dr_mosconi Click here to find out more about Newson Health
234 - Breast cancer treatment and HRT
Dec 12 2023
234 - Breast cancer treatment and HRT
Content advisory: this podcast contains themes of mental health and suicide. Dr Louise is joined by her patient Trudie Jennings in this episode to talk about the complexities around HRT during and after treatment for breast cancer. Trudie describes how she started HRT to successfully manage crippling anxiety and other menopause symptoms and a few months later she was diagnosed with an aggressive breast cancer. NICE guidance states women should stop taking systemic HRT if they are diagnosed with breast cancer. However, after careful discussion with her cancer doctor and nurse, Trudie decided to continue with HRT during her treatment as, for her, the menopause symptoms were more challenging than her cancer treatment. Trudie and Dr Louise discuss shared decision making and informed consent, and how important it is for women with and after breast cancer to be fully informed about potential risks, benefits and uncertainties about HRT following a breast cancer diagnosis so they can make the best decision that is right for them. Trudie’s three tips for women who have had breast cancer and are struggling with their menopause:  Know that as a patient you do have choices about whether to start or continue HRT after breast cancer treatment.Speak to your doctors and nurses and be informed so that you can make the right, personalised, decision for yourself. Trudie has found her healthcare professionals in cancer care open and helpful when discussing her need for HRT.You know your own body best, so listen to your body to get the treatment that will be best support you. Contact the Samaritans for 24-hour, confidential support by calling 116 123 or email jo@samaritans.org Click here to find out more about Newson Health